DNALite Therapeutics, Inc. is an early-stage preclinical biotechnology company committed on bringing the next-generation of drugs to the gastrointestinal tract. Currently for some gastrointestinal diseases, such as colorectal cancer and Crohn's disease, complete or partial removal of the colon and/or rectum is the only treatment  Our aim is to prevent not manage the progression of theses diseases. We are doing this by harnessing our proprietary technology to carry DNA to cells that drive these diseases. 



Find out about our team.

Learn More →

Take Action

If you or your loved one suffers from a devastating gastrointestinal disease, learn how you can help us accelerate our research.

Find Out How →